Skip to content

Ayurvedic treatment of Migraine

Role of Laghu Sutashekhara Rasa and Brihat Dashmoola Taila Nasya in the management of Migraine

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/017989
Enrollment
100
Registered
2019-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: In group A- Laghu Sutashekhara Rasa,Brihat Dashmoola Taila: laghu sutashekar rasa Dose - 500 mg Tablet thrice per day orally after meal with luke warm water. Duration - 02 Months. Dos

Sponsors

Institute for Post Graduate Training and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in the age group 18 to 60 years, presenting with signs and symptoms of Migraine will be included in the study. 2. The diagnosis of the disease shall be done on the basis of clinical manifestations like recurrent attacks of headache, mostly unilateral in site, variable in intensity, frequency and duration with or without nausea, vomiting, aura and GI tract symptoms.

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years and above 60 years. 2. Patients suffering from any chronic debilitating disease, with other neurological pathology, E.N.T. pathology, and cases which required surgical intervention will be excluded from study. 3. Patients suffering from Sinusitis, Hypertension, Secondary headache caused by meningitis, tumor, encephalitis, cervical spondylitis and refractive errors will be excluded from study. 4. Patients using any other systemic drugs which may alter the results of study. 5. Patients who need psychiatric treatment will be excluded.

Design outcomes

Primary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of the disease in the sign and symptoms based on the standard pattern will be applied before and after treatment.Timepoint: Improvement will be assessed on the basis of relief found in cardinal symptoms of the disease in the sign and symptoms based on the standard pattern will be applied before and after treatment.

Secondary

MeasureTime frame
MIDAS Criteria will be applied before and after treatmentTimepoint: 60 days

Countries

India

Contacts

Public ContactDr D B Vaghela

Institute for Post Graduate Training And Research Centre

drvaghela@rediffmail.com09825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026